Metavid

Video archive of the US Congress

House Proceeding 12-08-09 on Dec 8th, 2009 :: 1:17:35 to 1:20:15
Total video length: 2 hours 43 minutes Stream Tools: Stream Overview | Edit Time

Note: MetaVid video transcripts may contain inaccuracies, help us build a more perfect archive

Download OptionsEmbed Video

Views:112 Duration: 0:02:40 Discussion

Previous speech: Next speech:

Lois Capps

1:17:31 to 1:17:51( Edit History Discussion )

Lois Capps: of the house of representatives that congress s increased federal funding for continued type 1 diabetes research. the speaker pro tempore: pursuant to the rule, the gentlewoman from california, mrs. capps, and the gentleman from nebraska, mr. tery, ea will control 20 minutes. the chair recognizes the gentlewoman from california. mrs. capps: mr. speaker, i ask unanimous consent that all members may have five

Lois Capps

1:17:35 to 1:20:15( Edit History Discussion )
Speech By: Lois Capps

Lois Capps

1:17:52 to 1:18:12( Edit History Discussion )

Lois Capps: legislative days in which t revise and extends their remarks and include extraneous materials on the record. the speaker pro tempore: without objection. mrs. capps: mr. speaker, i yield to myself such time as i may consume. the speaker pro tempore: the gentlewoman is recognized. mrs. capps: mr. speaker, i rise today in support of house resolution 35 expressing the sense of the house that congress should provide increased federal

Lois Capps

1:18:13 to 1:18:35( Edit History Discussion )

Lois Capps: research funding for type 1 diabetes. the diabetes is one of the most prevalent conditions in the united states today. according to the centers for disease control and prevention, nearly 24 million americans, that's roughly 8% of the united states population, have diabetes. direct and indirect costs of diabetes totaled $174 billion in

Lois Capps

1:18:36 to 1:18:57( Edit History Discussion )

Lois Capps: 2007 and $120 billion of which was direct medical costs attributable to diabetes. three million americans have type 1 diabetes which results when the body's immune system destroys insulin-producing cells in the pancreatic rass that regulate blood glucose levels. scrids with this depend on insulin.

Lois Capps

1:18:58 to 1:19:19( Edit History Discussion )

Lois Capps: even with adherence to insulin treatment, individuals with type 1 diabetes are still very vulnerable to many complications that this disease offers and that is blindness, kidney failure d amputation. as a school nurse, i became intimately aware of the challenges that are faced by children with type 1 diabetes and the impact that it has on their families and on their classmates as well.

Lois Capps

1:19:20 to 1:19:43( Edit History Discussion )

Lois Capps: during the years i cared for those students we discussed pot tension for a cure -- the potential for a cure, that a cure would be available by now. unfortunately we still have a ways to go. federal funding of diabetes research has resulted in trendou understanding and treatment of the disease. we've successfully determined underlying genetic and environmental causes of diabetes

Lois Capps

1:19:44 to 1:20:04( Edit History Discussion )

Lois Capps: and are testing and promising new treatments but there's still much work to be done. the national institutes of health have devoted $433 million in fiscal year 2001 for type 1 diabetes research. this resolution calls for a doubling of annual n.i.h. funding to meet leading researchers' estimates of the funding needed to accomplish

Lois Capps

1:20:05 to 1:20:15( Edit History Discussion )

Lois Capps: n.i.h.'s six goals related to type 1 diabetes. mr. speaker, i'm pleased to join my colleagues in kuhling -- calling for passage of this resoluti research funding to find a cure for type 1 diabetes.

Personal tools

MetaVid is a non-profit project of UC Santa Cruz and the Sunlight Foundation. Learn more About MetaVid

The C-SPAN logo and other servicemarks that may be found in video content are the property of their respective trademark holders. None of these trademark holders are affiliated with Metavid